Transforming care for rheumatoid arthritis patients through symptom monitoring

FHS
June 22, 2024
6:17 am

Researchers at The University of Manchester are to trial a system that allows people living with rheumatoid arthritis to send their daily symptoms securely to their health record, in a first for the NHS.

Ascidian launches first-ever clinical study of RNA exon editor for vision loss – Pharmaceutical Technology

Share this article ACDN-01 is the only RNA exon editing treatment in clinical stages for Stargardt disease. Credits: Monet_3k/Shutterstock.com Ascidian Therapeutics’ lead RNA exon editor

January 29, 2024

Understanding brain coupling in conversations through linguistic context

When two people interact, their brain activity becomes synchronized, but it was unclear until now to what extent this “brain-to-brain coupling” is due to linguistic

August 2, 2024

Roche’s Columvi receives marketing approval in Europe – Pharmaceutical Technology

Columvi is a CD20xCD3 T-cell engaging bispecific antibody designed to treat R/R DLBCL and is given for a fixed time, a maximum of 12 cycles.

July 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.